DocuSign, Inc. (DocuSign®) today launched its DocuSign Spring ’15 Release, with business-specific enhancements to the New DocuSign Experience. Now, the next generation of DocuSign’s “best-in-class” user experience provides powerful Digital Transaction Management (DTM) capabilities for organizations of all sizes in an easy-to-use interface that makes it easier, faster and more intuitive than ever to send and manage documents: www.docusign.com/docusign-spring-15-release.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7312254-docusign-new-user-experience/
The current student loan debt crisis in the U.S. is real. Total student loan debt currently stands at more than $1.16 trillion. And, according to the Federal Reserve Bank of New York, student loans represent the highest amount of delinquent debt compared to all other forms of household debt, including mortgages, auto loans, and credit cards.
Gaining a college education has long been among the most important first steps towards obtaining a happy and prosperous life. The reality, however, is that most college graduates are starting their adult life deep in debt, and feeling stressed and completely unprepared to manage their financial lives. The good news is that the government has created programs to help borrowers reduce the burden caused by student loan debt. To learn more about these government programs, visit StudentAid.ed.gov.
Money Management International (MMI), along with other nonprofit organizations and consumer advocate groups, have taken additional steps to help struggling student loan borrowers understand their repayment plan options, find solutions for managing other debt obligations, and create realistic action plans for reaching overall financial success.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7406151-mmi-student-loan-debt/
Take the #PepsiChallenge and step out of your routine to do something different.
Beginning today and continuing throughout 2015, this will become the hallmark of the Pepsi® Challenge™ as Pepsi unleashes its biggest socially-led, content driven initiative ever with a variety of global and local challenges designed to galvanize consumers around the world to defy convention, make every moment – big or small – epic, and truly “Live for Now.” Issued on Pepsi social and digital channels and via renowned ambassadors from around the world, #PepsiChallenge will incite consumers to take on different challenges for amazing life experiences and rewards.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7465451-2015-pepsi-challenge/
As the world’s fastest growing Enterprise Big Data and Web/Cloud storage company, DDN® Storage today announced sustained upward momentum led by profitable, double digit year-over-year growth worldwide. This significant momentum is the direct result of strong market demand across Enterprise and Web/Cloud sectors for DDN’s storage and data management solutions.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7429757-ddn-q4-2014-growth-profitability/
Chiasma, Inc., a U.S. privately–held biopharma company developing octreotide capsules for the orphan condition acromegaly, today announced two new studies presented at the 97th Endocrine Society (ENDO) Annual Meeting in San Diego, Calif. The studies provide additional data from Chiasma’s Phase III trial and new findings on the patient burden of current injection therapies.
“We now have data to help clinicians determine whether octreotide capsules, if approved, are likely to help their patient with acromegaly maintain response,” said Shlomo Melmed, M.D., senior vice president and dean, Cedars–Sinai Medical Center, Los Angeles and global study principal investigator. “Furthermore, the Phase III results show the safety and efficacy of octreotide capsules can be reliably determined within 12 weeks of initiating therapy.”
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7436451-endo-chiasma-clinical-data/
Typical bathroom products like shampoo bottles, toilet paper rolls and toothpaste boxes are significantly less likely to be recycled than kitchen products according to survey results released today by the Ad Council. Nonprofits Keep America Beautiful and the Ad Council have joined with Unilever to expand the conversation around recycling and motivate more Americans to remember to recycle in the bathroom by launching a new phase of the national, award-winning “I Want To Be Recycled” communications campaign, featuring a brand new series of broadcast and digital PSAs.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7444951-keep-america-beautiful-recycle/
Patients and scientists from across the country are featured in the latest “From Hope to Cures” ad campaign launched today by the Pharmaceutical Research and Manufacturers of America (PhRMA), which represents the country’s leading biopharmaceutical researchers and biotechnology companies.
This continuation of PhRMA’s “From Hope to Cures” campaign, first launched in January 2014, highlights the value biopharmaceutical innovation provides to patients, society and the economy. The latest ad campaign, featuring print, radio and digital advertising, highlights the stories of patients who benefit from the medicines developed by biopharmaceutical companies and the scientists who work every day to develop life-saving treatments and cures.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7350552-phrma-from-hope-to-cures/
WebMD Health Corp. (NASDAQ:WBMD), the leading source of health information, today announced the premiere of WebMD’s Future of Health with Robin Roberts, developed in collaboration with Good Morning America co-anchor Robin Roberts and her independent production company, Rock’n Robin Productions. Each Future of Health episode presents stories about cutting-edge medical breakthroughs, inspiring individuals working to improve people’s lives, and the people that are benefiting from their efforts. The five-part digital video series and related programming, which include feature stories, slideshows, quizzes and a host of video extras, are available at http://webmd.com/futureofhealth.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7282551-webmd-future-of-health/
Today, the Pharmaceutical Research and Manufacturers of America (PhRMA) released a new report, “A Decade of Innovation in Rare Diseases,” to document the significant progress made in the last 10 years in understanding a broad range of rare diseases and translating this knowledge into groundbreaking therapies for a variety of patient populations.
The report illustrates that more than 230 new medicines to treat rare or “orphan” diseases were approved by the U.S. Food and Drug Administration (FDA) in the last decade, and there are currently more than 450 orphan drugs in development.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7350554-phrma-report-innovation-rare-diseases/
Texas Instruments (TI) (NASDAQ: TXN) today announced the new SimpleLink™ ultra-low power wireless microcontroller (MCU) platform that helps customers go battery-less with energy harvesting or enjoy always-on, coin cell-powered operation for multiple years. With this industry-first technology, customers have the flexibility to develop products that support multiple wireless connectivity standards using a single-chip and identical RF design. The SimpleLink ultra-low power platform supports Bluetooth® low energy, ZigBee®, 6LoWPAN, Sub-1 GHz, ZigBee RF4CE™ and proprietary modes up to 5Mbps. This platform expands TI’s SimpleLink portfolio, the broadest, lowest power and easiest to use wireless connectivity offering in the industry for the Internet of Things (IoT). For more information, visit www.ti.com/simplelinkulp.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/70647527-texas-instruments-simplelink/
Results from a large retrospective data analysis published in the American Journal of Transplantation (AJT) today, showed that liver transplantation patients who were treated early with Advagraf experienced a significantly increased graft survival benefit of 8% at 3 years post-transplant compared with patients treated with the current standard of care, tacrolimus immediate release (twice daily).
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7451251-advagraf-prolonged-release-tacrolimus/
Significant advances toward cures for blood cancer patients, many of which were funded by The Leukemia & Lymphoma Society (LLS) over the past 65 years, are among the dramatic highlights featured in Ken Burns presents CANCER: THE EMPEROR OF ALL MALADIES, a film by Barak Goodman, to air on PBS stations nationwide from March 30-April 1. The documentary series is based on the Pulitzer Prize-winning book by Siddhartha Mukherjee, MD, The Emperor of All Maladies: A Biography of Cancer.
LLS has been a driving force behind treatment breakthroughs for patients with blood cancers, including leukemia, lymphoma and myeloma. As the world’s largest voluntary health agency dedicated to finding cures for blood cancer patients, LLS has invested more than $1billion in research to advance lifesaving treatments and cures.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7409151-lls-cancer-research-pbs-series/
